US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BillionToOne, Inc.

69.55

-1.8900-2.65%

Post-market: 69.550.00000.00%18:11 EDT

Volume:302.53K

Turnover:21.24M

Market Cap:3.20B

PE:496.79

High:72.34

Open:70.01

Low:67.70

Close:71.44

52wk High:138.70

52wk Low:61.96

Shares:45.97M

Float Shares:8.22M

Volume Ratio:1.18

T/O Rate:3.68%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.1400

EPS(LYR):0.1400

ROE:2.30%

ROA:2.14%

PB:6.66

PE(LYR):496.79

Loading ...

Overview Company News Filings

Billiontoone Provides Guidance for 2026

THOMSON REUTERS

Billiontoone Inc FY2026 REV View $402.4 Mln -- Lseg Ibes Data

THOMSON REUTERS

BillionToOne Provides Guidance for 2026

BRIEF-Billiontoone Announces Selection Of Northstar Select® As The New Liquid Biopsy Test

BillionToOne Partners with National Cancer Center Hospital East for Liquid Biopsy Study in Japan

Billiontoone- Ultra-Sensitive Liquid Biopsy Expanding Precision Medicine Access in Japan With Treatment-Resistant Non-Small Cell Lung Cancer

THOMSON REUTERS

Billiontoone Announces Selection of Northstar Select® as the New Liquid Biopsy Test for Lc-Scrum-TRY Clinical Study at National Cancer Center Hospital East

THOMSON REUTERS

Guggenheim Initiates BillionToOne at Buy With $120 Price Target

MT Newswires Live

BillionToOne Inc. Files Initial Statement of Beneficial Ownership for Director Anthony Pagano

BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference

BillionToOne (BLLN) Revenue Surge Tests Bullish Growth Narrative Despite Ongoing EPS Losses

Simply Wall St.

BillionToOne Is Maintained at Overweight by JP Morgan

BillionToOne Price Target Maintained With a $160.00/Share by BTIG

U.S. RESEARCH ROUNDUP-JP Morgan, Pepsico, Pfizer

Billiontoone Inc : JP Morgan Cuts Target Price to $145 From $150

THOMSON REUTERS

GUIDANCE: (BLLN) BillionToOne Expects Full Year 2025 Revenue Range $293M - $299M, vs. FactSet Est of $288.6M

MT Newswires Live

Earnings Flash (BLLN) BillionToOne Posts Q3 EPS $0.10, vs. FactSet Est of $0.14

MT Newswires Live

Press Release: BillionToOne Appoints Anthony Pagano to Board of Directors as Audit Committee Chair

BillionToOne Q3 EPS $0.10 Misses $0.16 Estimate, Sales $83.500M Beat $82.814M Estimate

BillionToOne Q3 net income hits USD 1.5 million, reversing from loss, as revenue growth nears doubling

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BLLN/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"BLLN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BLLN\",,,,,undefined,":{"symbol":"BLLN","market":"US","secType":"STK","nameCN":"BillionToOne, Inc.","latestPrice":69.55,"timestamp":1774641600000,"preClose":71.44,"halted":0,"volume":302530,"hourTrading":{"tag":"盘后","latestPrice":69.55,"preClose":69.55,"latestTime":"18:11 EDT","volume":109,"amount":7581.05,"timestamp":1774649480261,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.026455767077267645,"floatShares":8222132,"shares":45965800,"eps":0.139999,"marketStatus":"Market Closed","change":-1.89,"latestTime":"03-27 16:00:00 EDT","open":70.01,"high":72.34,"low":67.7,"amount":21242423.31381,"amplitude":0.06495,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.139999,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":0,"listingDate":1762405200000,"exchange":"NASDAQ","adjPreClose":71.44,"postHourTrading":{"tag":"盘后","latestPrice":69.55,"preClose":69.55,"latestTime":"18:11 EDT","volume":109,"amount":7581.05,"timestamp":1774649480261,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.180137,"impliedVol":0.8571,"impliedVolPercentile":0.5769},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BLLN\",,,,,undefined,":{"symbol":"BLLN","floatShares":8222132,"roa":"2.14%","roe":"2.30%","lyrEps":0.139999,"volumeRatio":1.180137,"shares":45965800,"dividePrice":0,"high":72.34,"amplitude":0.06495,"preClose":71.44,"low":67.7,"week52Low":61.96,"pbRate":"6.66","psRate":"10.48","week52High":138.7,"institutionHeld":0,"latestPrice":69.55,"eps":0.139999,"divideRate":0,"volume":302530,"delay":0,"ttmEps":0.139999,"open":70.01,"prevYearClose":81.84,"prevWeekClose":76,"prevMonthClose":76.33,"prevQuarterClose":81.84,"fiveDayClose":76,"twentyDayClose":76.33,"sixtyDayClose":85.09},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BLLN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-04","symbol":"BLLN","fiscalQuarterEnding":"2025/12","expectedEps":0.07,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1772600400000,"reportTimeType":"post","actualEps":0.11}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BLLN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BLLN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.25,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.25,"analysts":8,"updateTime":1767758400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BLLN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BLLN","date":"2026-03-27","current":496.789263,"percent":0.916667,"low":-448.462026,"twenty":-373.942615,"median":-340.551933,"eighty":-137.005187,"high":1253.312428,"avg":-67.635293,"sd":541.888109,"marketCap":3283797609},"quantilePoints":[{"date":"2025-11-07","current":-159.132389,"twenty":-144.871341,"median":-123.479768,"eighty":-102.088195,"marketCap":4871838088},{"date":"2025-11-14","current":-130.808752,"twenty":-151.11734,"median":-148.702746,"eighty":-133.870451,"marketCap":4004709939},{"date":"2025-11-21","current":-139.763053,"twenty":-149.199396,"median":-143.65591,"eighty":-132.43601,"marketCap":4278845862},{"date":"2025-11-28","current":-193.061188,"twenty":-160.680767,"median":-147.409996,"eighty":-136.31572,"marketCap":5910568267},{"date":"2025-12-05","current":-154.265054,"twenty":-170.43011,"median":-151.565786,"eighty":-139.763053,"marketCap":4722824636},{"date":"2025-12-12","current":-402.174044,"twenty":-192.645939,"median":-154.739624,"eighty":-142.260908,"marketCap":4459707974},{"date":"2025-12-19","current":-394.166884,"twenty":-381.825952,"median":-160.680767,"eighty":-145.050911,"marketCap":4370916580},{"date":"2025-12-26","current":-356.359883,"twenty":-394.819014,"median":-167.642009,"eighty":-145.90398,"marketCap":3951674738},{"date":"2026-01-02","current":-337.786574,"twenty":-386.762325,"median":-177.845273,"eighty":-147.668546,"marketCap":3745715318},{"date":"2026-01-09","current":-361.519135,"twenty":-391.80601,"median":-193.061188,"eighty":-149.075233,"marketCap":4008885688},{"date":"2026-01-16","current":-390.947511,"twenty":-392.928663,"median":-348.806737,"eighty":-150.668895,"marketCap":4335216947},{"date":"2026-01-23","current":-373.777519,"twenty":-391.905068,"median":-351.20063,"eighty":-151.898045,"marketCap":4144818905},{"date":"2026-01-30","current":-335.186311,"twenty":-391.343741,"median":-353.924715,"eighty":-153.143881,"marketCap":3716880999},{"date":"2026-02-06","current":-351.448274,"twenty":-390.369675,"median":-351.20063,"eighty":-154.64471,"marketCap":3897209914},{"date":"2026-02-13","current":-370.186679,"twenty":-386.432133,"median":-353.511975,"eighty":-156.781473,"marketCap":4105000084},{"date":"2026-02-20","current":-373.199682,"twenty":-384.03824,"median":-354.729559,"eighty":-159.442065,"marketCap":4138411279},{"date":"2026-02-27","current":-294.737772,"twenty":-381.743404,"median":-353.140509,"eighty":-161.657766,"marketCap":3268347151},{"date":"2026-03-06","current":1131.59692,"twenty":-381.041746,"median":-351.324452,"eighty":-161.657766,"marketCap":3303131409},{"date":"2026-03-13","current":1004.754526,"twenty":-379.539371,"median":-347.155776,"eighty":-152.770157,"marketCap":2932878462},{"date":"2026-03-20","current":1165.286087,"twenty":-378.375444,"median":-343.915766,"eighty":-146.634347,"marketCap":3401470088},{"date":"2026-03-27","current":1124.973487,"twenty":-373.942615,"median":-340.551933,"eighty":-137.005187,"marketCap":3283797609}],"updateTime":1774740765114},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BLLN\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2602510537","title":"Billiontoone Provides Guidance for 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2602510537","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602510537?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:05","pubTimestamp":1768223100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nTUA6TJYRV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BLLN","BK4196"],"gpt_icon":0},{"id":"2602251064","title":"Billiontoone Inc  FY2026 REV View $402.4 Mln -- Lseg Ibes Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2602251064","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602251064?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:05","pubTimestamp":1768223100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nTUA6TJYRV:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","BLLN"],"gpt_icon":0},{"id":"2602031510","title":"BillionToOne Provides Guidance for 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2602031510","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602031510?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:05","pubTimestamp":1768223100,"startTime":"0","endTime":"0","summary":"MENLO PARK, Calif., Jan.  12, 2026  (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/12/3216869/0/en/BillionToOne-Provides-Guidance-for-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLLN","BK4196"],"gpt_icon":0},{"id":"2601816803","title":"BRIEF-Billiontoone Announces Selection Of Northstar Select® As The New Liquid Biopsy Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2601816803","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601816803?lang=en_us&edition=fundamental","pubTime":"2026-01-06 23:11","pubTimestamp":1767712280,"startTime":"0","endTime":"0","summary":"BRIEF-Billiontoone Announces Selection Of Northstar Select As The New Liquid Biopsy Test Jan 6 (Reuters) - BillionToOne Inc BLLN.O:BILLIONTOONE ANNOUNCES SELECTION OF NORTHSTAR SELECT AS THE NEW LIQUI","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nTUA2KWDPY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BLLN"],"gpt_icon":0},{"id":"2601881864","title":"BillionToOne Partners with National Cancer Center Hospital East for Liquid Biopsy Study in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2601881864","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601881864?lang=en_us&edition=fundamental","pubTime":"2026-01-06 22:01","pubTimestamp":1767708084,"startTime":"0","endTime":"0","summary":"BillionToOne Inc. has announced a collaboration with the National Cancer Center Hospital East  in Japan, as its ultra-sensitive liquid biopsy test, Northstar Select, has been selected for use in the LC-SCRUM-TRY clinical study. This partnership aims to expand precision medicine access for patients with treatment-resistant non-small cell lung cancer  in Japan. By integrating Northstar Select into the nationwide, multi-center study, the collaboration seeks to better characterize drug-resistant cancers and identify more effective therapies for affected patients.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Billiontoone Inc. published the original content used to generate this news brief via PR Newswire  on January 06, 2026, and is solel","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nNDL37XJQv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BK4160","BK4233","DBRG","BK4135","BK4205","BLLN"],"gpt_icon":0},{"id":"2601818237","title":"Billiontoone- Ultra-Sensitive Liquid Biopsy Expanding Precision Medicine Access in Japan With Treatment-Resistant Non-Small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2601818237","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601818237?lang=en_us&edition=fundamental","pubTime":"2026-01-06 22:00","pubTimestamp":1767708008,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nTUA2KWDPY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","BLLN"],"gpt_icon":0},{"id":"2601081860","title":"Billiontoone Announces Selection of Northstar Select® as the New Liquid Biopsy Test for Lc-Scrum-TRY Clinical Study at National Cancer Center Hospital East","url":"https://stock-news.laohu8.com/highlight/detail?id=2601081860","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601081860?lang=en_us&edition=fundamental","pubTime":"2026-01-06 22:00","pubTimestamp":1767708008,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nTUA2KWDPY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","BLLN"],"gpt_icon":0},{"id":"2601813890","title":"Guggenheim Initiates BillionToOne at Buy With $120 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2601813890","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601813890?lang=en_us&edition=fundamental","pubTime":"2026-01-06 21:19","pubTimestamp":1767705564,"startTime":"0","endTime":"0","summary":"BillionToOne, Inc. Class A (BLLN) has an average rating of overweight and mean price target of $137.83, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic rese","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BLLN"],"gpt_icon":0},{"id":"2601285450","title":"BillionToOne Inc. Files Initial Statement of Beneficial Ownership for Director Anthony Pagano","url":"https://stock-news.laohu8.com/highlight/detail?id=2601285450","media":"Reuters","labels":["executive","shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601285450?lang=en_us&edition=fundamental","pubTime":"2026-01-06 09:51","pubTimestamp":1767664292,"startTime":"0","endTime":"0","summary":"Billiontoone Inc. has filed an initial statement of beneficial ownership  with the U.S. Securities and Exchange Commission. The filing lists Anthony Pagano as a Director of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Billiontoone Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 05, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nNDL6lfGY0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"BillionToOne Inc. Files Initial Statement of Beneficial Ownership for Director Anthony Pagano","news_tag":"executive,shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLLN","BK4196"],"gpt_icon":0},{"id":"2593418893","title":"BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2593418893","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593418893?lang=en_us&edition=fundamental","pubTime":"2025-12-23 21:05","pubTimestamp":1766495100,"startTime":"0","endTime":"0","summary":"MENLO PARK, Calif., Dec.  23, 2025  (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/23/3209856/0/en/BillionToOne-to-Participate-in-the-44th-Annual-J-P-Morgan-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2028103732.USD","LU2089284900.SGD","XBI","LU0225283273.USD","LU0882574139.USD","LU0557290698.USD","LU0158827781.USD","LU1732799900.SGD","LU1668664300.SGD","LU0795875169.SGD","LU1989772923.USD","LU1548497426.USD","BK4585","BLLN","LABU","LU1791710400.SGD","BK4534","IE00BKVL7J92.USD","BK4516","BK4504","LU0029874061.USD","LU2357305700.SGD","BK4127","LU0106831901.USD","LU1720051108.HKD","HCSG","LU1791710582.SGD","LU2111349929.HKD","LU0795875086.SGD","LU2133065610.SGD","LU1162221912.USD","BK4137","LU0912757837.SGD","LU0528227936.USD","LU0971096721.USD","LU0006306889.USD","LU2023251221.USD","LU1363072403.SGD","LU2271345857.HKD","LU0314104364.USD","IE00BZ1G4Q59.USD","LU1720051017.SGD","BK4196","LU1244550577.SGD","LU2347655156.SGD","BK4581","LU1732800096.USD","LU1244550494.USD","LU0098860793.USD","XLV"],"gpt_icon":0},{"id":"2590126665","title":"BillionToOne (BLLN) Revenue Surge Tests Bullish Growth Narrative Despite Ongoing EPS Losses","url":"https://stock-news.laohu8.com/highlight/detail?id=2590126665","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590126665?lang=en_us&edition=fundamental","pubTime":"2025-12-11 22:32","pubTimestamp":1765463529,"startTime":"0","endTime":"0","summary":"BillionToOne (BLLN) has just put another big quarter on the board, with Q3 2025 revenue at about $62.8 million and Basic EPS of roughly -$0.20, as investors gauge how fast the top line can outrun still negative earnings. The company has seen revenue move from roughly $34.5 million in early 2024 to about $41.7 million later that year and then to $62.8 million in 2025, while Basic EPS shifted from about -$0.76 to -$1.30 and then to -$0.20 over the same stretch, setting up a story where rapid...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-blln/billiontoone/news/billiontoone-blln-revenue-surge-tests-bullish-growth-narrati","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-blln/billiontoone/news/billiontoone-blln-revenue-surge-tests-bullish-growth-narrati","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4112","BLLN","BK4196"],"gpt_icon":0},{"id":"2590393915","title":"BillionToOne Is Maintained at Overweight by JP Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2590393915","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590393915?lang=en_us&edition=fundamental","pubTime":"2025-12-11 00:13","pubTimestamp":1765383180,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BLLN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 10, 2025 11:13 ET (16:13 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLLN"],"gpt_icon":0},{"id":"2590585228","title":"BillionToOne Price Target Maintained With a $160.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2590585228","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590585228?lang=en_us&edition=fundamental","pubTime":"2025-12-10 18:34","pubTimestamp":1765362840,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BLLN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 10, 2025 05:34 ET (10:34 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLLN"],"gpt_icon":0},{"id":"2590054413","title":"U.S. RESEARCH ROUNDUP-JP Morgan, Pepsico, Pfizer","url":"https://stock-news.laohu8.com/highlight/detail?id=2590054413","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590054413?lang=en_us&edition=fundamental","pubTime":"2025-12-10 14:43","pubTimestamp":1765349009,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-JP Morgan, Pepsico, Pfizer Dec 10 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including JP Morgan, Pepsi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nL4N3XG0E5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BRZE","APGE","CHD","IE00B3PB1722.GBP","ASO","CMCSA","CBRL","SG9999011175.SGD","CNM","ABBV","CAPR","LU0096364046.USD","BDX","AMGN","ASMB","AU","ELAN","ANDE","ANF","LU0942090050.USD","PLAY","BMY","AZO","LU2133065610.SGD","CPB","LU2746668974.SGD","DE","DBI","CMC","IE00B894F039.SGD","AVAV","AVBP","AMRZ","BLLN","LU1868836914.USD","CAT","SATS","BIIB","BWB","COF","IE00B19Z9Z06.USD","CARR","IE00BDGV0183.EUR","LU1868837136.USD","LU0321505868.SGD","APD","CF","CVS","T","BTI"],"gpt_icon":1},{"id":"2590308070","title":"Billiontoone Inc : JP Morgan Cuts Target Price to $145 From $150","url":"https://stock-news.laohu8.com/highlight/detail?id=2590308070","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590308070?lang=en_us&edition=fundamental","pubTime":"2025-12-10 13:57","pubTimestamp":1765346243,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nFWN3XF0ZI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BLLN","BK4196"],"gpt_icon":0},{"id":"2590072321","title":"GUIDANCE: (BLLN) BillionToOne Expects Full Year 2025 Revenue Range $293M - $299M, vs. FactSet Est of $288.6M","url":"https://stock-news.laohu8.com/highlight/detail?id=2590072321","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590072321?lang=en_us&edition=fundamental","pubTime":"2025-12-10 05:14","pubTimestamp":1765314855,"startTime":"0","endTime":"0","summary":"GUIDANCE: (BLLN) BillionToOne Expects Full Year 2025 Revenue Range $293M - $299M, vs. FactSet Est of $288.6M","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BLLN"],"gpt_icon":0},{"id":"2590532170","title":"Earnings Flash (BLLN) BillionToOne Posts Q3 EPS $0.10, vs. FactSet Est of $0.14","url":"https://stock-news.laohu8.com/highlight/detail?id=2590532170","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590532170?lang=en_us&edition=fundamental","pubTime":"2025-12-10 05:13","pubTimestamp":1765314834,"startTime":"0","endTime":"0","summary":"Earnings Flash (BLLN) BillionToOne Posts Q3 EPS $0.10, vs. FactSet Est of $0.14","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BLLN"],"gpt_icon":0},{"id":"2590212253","title":"Press Release: BillionToOne Appoints Anthony Pagano to Board of Directors as Audit Committee Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2590212253","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590212253?lang=en_us&edition=fundamental","pubTime":"2025-12-10 05:07","pubTimestamp":1765314420,"startTime":"0","endTime":"0","summary":"MENLO PARK, Calif., Dec. 9, 2025 /PRNewswire/ -- BillionToOne, Inc. , a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced the appointment of Anthony Pagano to its Board of Directors, effective January 1, 2026. Mr. Pagano will also serve as Chair of the Audit Committee.Mr. Pagano is currently Chief Financial Officer and Executive Vice President of Genmab, a leading international biotechnology company, a position he has held since March 2020. He joined Genmab in December 2007, establishing a strong track record of driving financial performance and strategic growth throughout his tenure. During Mr. Pagano's tenure, Genmab has grown from $100M in annual revenues to more than $3B, developing, launching and commercializing differentiated and innovative antibody therapeutics that improve the lives of patients.Before his role at Genmab, Mr. Pagano served as Corporate Controller and Senior Director of B","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLLN","BK4555","BK4196","03160","BK4588","BK4604","TM","BK4585","BK4099"],"gpt_icon":0},{"id":"2590232121","title":"BillionToOne Q3 EPS $0.10 Misses $0.16 Estimate, Sales $83.500M Beat $82.814M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2590232121","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590232121?lang=en_us&edition=fundamental","pubTime":"2025-12-10 05:06","pubTimestamp":1765314419,"startTime":"0","endTime":"0","summary":"BillionToOne (NASDAQ:BLLN) reported quarterly earnings of $0.10 per share which missed the analyst consensus estimate of $0.16 by 37.5 percent.  The company reported quarterly sales of $83.500 million which beat the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/12/49291885/billiontoone-q3-eps-0-10-misses-0-16-estimate-sales-83-500m-beat-82-814m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"BillionToOne Q3 EPS $0.10 Misses $0.16 Estimate, Sales $83.500M Beat $82.814M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLLN"],"gpt_icon":0},{"id":"2590421321","title":"BillionToOne Q3 net income hits USD 1.5 million, reversing from loss, as revenue growth nears doubling","url":"https://stock-news.laohu8.com/highlight/detail?id=2590421321","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590421321?lang=en_us&edition=fundamental","pubTime":"2025-12-10 05:05","pubTimestamp":1765314316,"startTime":"0","endTime":"0","summary":"Billiontoone Inc. reported Q3 2025 operating income of USD 9.6 million, compared to an operating loss in the prior-year period. Operating margin for the quarter was 11.5%. Net income available to common shareholders for Q3 2025 was USD 1.5 million, or USD 0.10 per diluted share. As of September 30, 2025, cash and cash equivalents totaled USD 195.2 million. The company expects full year 2025 total revenue of USD 293 million to USD 299 million, representing growth of 93% to 96% compared to full year 2024. Fourth quarter 2025 revenue is forecasted at USD 84 million to USD 90 million, an increase of 86% to 100% compared to the same period in 2024. Billiontoone Inc. also expects to report positive GAAP operating income for both Q4 2025 and the full year. The company raised gross proceeds of USD 314.0 million from its IPO, with net proceeds of USD 286.4 million.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nNDL3wG9Lj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","IE00BKPKM429.USD","LU0314104364.USD","LU2095319765.USD","IE00B3QW5Z07.USD","NDAQ","LU2210150020.SGD","BK4588","BK4112","BK4196","LU2210149790.SGD","SG9999014005.SGD","SG9999014039.USD","BK4585","BLLN","SG9999014021.USD","IE00BGHQF748.EUR","SG9999014013.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":3,"totalSize":103,"code":"91000000","status":"200"}]}}